샘플 요청 목록

 카트 문의
시장보고서
상품코드
1780820

세계의 형광 가이드 수술 시스템 시장

Fluorescence Guided Surgery Systems
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 370 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 형광 가이드 수술 시스템 시장은 2030년까지 4억 5,490만 달러에 달할 전망

2024년에 2억 860만 달러로 추정되는 세계의 형광 가이드 수술 시스템 시장은 2030년에는 4억 5,490만 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 13.9%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 SPY 시스템은 CAGR 13.0%를 기록하며, 분석 기간 종료시에는 2억 970만 달러에 달할 것으로 예측됩니다. PDE 시스템 분야의 성장률은 분석 기간에 CAGR 13.3%로 추정됩니다.

미국 시장은 5,680만 달러로 추정, 중국은 CAGR 18.4%로 성장 예측

미국의 형광 가이드 수술 시스템 시장은 2024년에는 5,680만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 9,630만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 18.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 10.3%와 12.3%로 예측됩니다. 유럽에서는 독일이 CAGR 11.0%로 성장할 것으로 예측됩니다.

세계의 형광 가이드 수술 시스템 시장 - 주요 동향과 촉진요인 정리

형광 유도 수술이 종양학 및 신경외과 분야의 게임 체인저가 되고 있는 이유는 무엇인가?

형광 유도 수술(Fluorescence Guided Surgery, FGS)은 형광증백제를 이용해 종양이나 림프절, 중요 조직을 실시간으로 가시화하여 수술의 정확성에 혁명을 일으키고 있습니다. 이 기술은 종양학, 신경외과, 최소 침습 수술에서 특히 가치가 있으며, 완전 절제를 위해서는 정확한 종양 마진 검출이 필수적입니다. 개인 맞춤형 암 치료의 채택 증가와 고형암의 유병률 증가가 FGS 시스템에 대한 수요를 견인하고 있습니다. 또한 근적외선(NIR) 이미징과 표적 형광 조영제의 발전은 수술의 정확도를 높이고 재발률을 낮추며 환자의 생존율을 향상시키고 있습니다. 정밀의료가 대중화됨에 따라 형광 유도 수술은 복잡한 수술의 표준이 되고 있습니다.

어떤 기술 발전이 형광 가이드 수술 시스템을 향상시키고 있는가?

분자 이미징, AI를 활용한 형광 매핑, 생체적합성 조영제의 획기적인 발전으로 FGS 시스템의 유효성을 높이고 있습니다. 암 조직에 선택적으로 결합하는 표적 형광 프로브의 개발로 종양의 가시성이 향상되고 건강한 구조에 대한 손상이 감소하고 있습니다. AI를 활용한 이미징 소프트웨어는 실시간 조직 감별을 가능하게 하고, 수술 중 외과의사를 보다 효과적으로 유도하고 있습니다. 또한 형광과 MRI 및 PET 스캔과 같은 다른 영상 양식을 결합한 하이브리드 영상 시스템은 더 나은 수술적 의사결정을 위한 다층적인 인사이트를 제공합니다. 로봇 보조 형광 유도 수술의 통합은 복잡한 수술의 정확도를 더욱 높이고 침습을 줄입니다.

규제와 시장 동향은 형광 유도 수술에 어떤 영향을 미치고 있는가?

FDA 및 EMA와 같은 규제기관은 형광 조영제 및 영상 시스템의 승인을 감독하고 그 안전성과 유효성을 보장합니다. 수술 중 영상과 정밀 종양학에 대한 관심이 높아지면서 암 치료 프로토콜에서 FGS의 채택이 가속화되고 있습니다. 또한 최소 침습 수술에 대한 수요는 병원들이 첨단 형광 유도 복강경 수술 시스템 및 로봇 수술 시스템에 투자하는 것을 촉진하고 있습니다. AI 지원 수술 계획 툴의 확대도 시장 성장에 영향을 미치고 있으며, 수술 전 종양 및 혈관 구조의 더 나은 매핑을 가능하게 하고 있습니다. 수술 기술이 발전함에 따라 형광 유도하 수술은 환자 예후를 개선하는 데 필수적인 툴이 되고 있습니다.

형광 가이드 수술 시스템 시장의 향후 성장 동력은?

FGS의 미래는 AI를 활용한 영상 분석, 차세대 형광 조영제, 로봇 보조 수술 플랫폼의 채택 확대로 형성되고 있습니다. 특정 암을 표적으로 하는 분자 이미징 염료의 개발로 종양의 위치 파악과 수술의 정확도를 더욱 향상시킬 수 있습니다. AI를 활용한 의사결정 지원 툴은 실시간 수술 중 가이던스를 강화하고, 수술 실수를 줄이며, 절제술의 완전성을 향상시킬 수 있습니다. 또한 원격 수술과 원격 로봇 수술의 적용이 확대되면 의료 서비스가 부족한 지역에서도 FGS를 더 쉽게 이용할 수 있게 됩니다. 정밀 수술에 대한 수요가 증가함에 따라 형광 유도 수술은 현대의 외과 종양학 및 신경외과를 계속 재정의할 것으로 보입니다.

부문

유형(SPY 시스템, PDE 시스템, VS3 이리듐 시스템, 기타), 수술(관혈적 수술, 복강경/내시경 수술), 애플리케이션(암수술, 심장혈관 외과, 기타)

조사 대상 기업의 예

  • Accuray Incorporated
  • Arthrex, Inc.
  • Bracco Imaging S.p.A.
  • Curadel LLC
  • Elekta AB
  • Fluoptics
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • Intuitive Surgical, Inc.
  • Karl Kaps GmbH & Co. KG
  • Karl Storz SE & Co. KG
  • Leica Microsystems(Danaher Corporation)
  • LI-COR Biosciences
  • Lumicell Inc.
  • Medtronic plc
  • Mizuho Medical Co., Ltd.
  • MolecuLight Inc.
  • NICO Corporation
  • Novadaq Technologies Inc.(Stryker)
  • Olympus Corporation

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.11

Global Fluorescence Guided Surgery Systems Market to Reach US$454.9 Million by 2030

The global market for Fluorescence Guided Surgery Systems estimated at US$208.6 Million in the year 2024, is expected to reach US$454.9 Million by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. SPY Systems, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$209.7 Million by the end of the analysis period. Growth in the PDE Systems segment is estimated at 13.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.8 Million While China is Forecast to Grow at 18.4% CAGR

The Fluorescence Guided Surgery Systems market in the U.S. is estimated at US$56.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$96.3 Million by the year 2030 trailing a CAGR of 18.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.3% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.0% CAGR.

Global Fluorescence Guided Surgery Systems Market - Key Trends & Drivers Summarized

Why Is Fluorescence Guided Surgery Becoming a Game-Changer in Oncology and Neurosurgery?

Fluorescence guided surgery (FGS) is revolutionizing surgical precision by enabling real-time visualization of tumors, lymph nodes, and critical tissues using fluorescent dyes. This technique is particularly valuable in oncology, neurosurgery, and minimally invasive procedures, where precise tumor margin detection is essential for complete resection. The growing adoption of personalized cancer treatment and the increasing prevalence of solid tumors are driving demand for FGS systems. Additionally, advancements in near-infrared (NIR) imaging and targeted fluorescence contrast agents are enhancing surgical accuracy, reducing recurrence rates, and improving patient survival. As precision medicine gains traction, fluorescence guided surgery is becoming a standard in complex surgical interventions.

What Technological Advancements Are Improving Fluorescence Guided Surgery Systems?

Breakthroughs in molecular imaging, AI-powered fluorescence mapping, and biocompatible contrast agents are enhancing the efficacy of FGS systems. The development of targeted fluorescent probes that bind selectively to cancerous tissues is improving tumor visibility and reducing damage to healthy structures. AI-driven imaging software is enabling real-time tissue differentiation, guiding surgeons more effectively during procedures. Additionally, hybrid imaging systems combining fluorescence with other imaging modalities, such as MRI and PET scans, are providing multi-layered insights for better surgical decision-making. The integration of robotic-assisted fluorescence guided surgery is further enhancing precision and reducing invasiveness in complex operations.

How Are Regulations and Market Trends Influencing Fluorescence Guided Surgery?

Regulatory agencies such as the FDA and EMA oversee the approval of fluorescence contrast agents and imaging systems, ensuring their safety and effectiveness. The increasing emphasis on intraoperative imaging and precision oncology is driving the adoption of FGS in cancer treatment protocols. Additionally, the demand for minimally invasive procedures is encouraging hospitals to invest in advanced fluorescence-guided laparoscopic and robotic surgery systems. The expansion of AI-assisted surgical planning tools is also influencing market growth, enabling better preoperative mapping of tumors and vascular structures. As surgical technology evolves, fluorescence guided surgery is becoming an indispensable tool for improving patient outcomes.

What’s Driving the Future Growth of the Fluorescence Guided Surgery Systems Market?

The future of FGS is being shaped by AI-enhanced imaging analytics, next-generation fluorescent contrast agents, and the increasing adoption of robotic-assisted surgical platforms. The development of targeted molecular imaging dyes for specific cancers will further improve tumor localization and surgical precision. AI-powered decision support tools will enhance real-time intraoperative guidance, reducing surgical errors and improving resection completeness. Additionally, the expansion of tele-surgical and remote robotic surgery applications will make FGS more accessible in underserved regions. As demand for precision surgery grows, fluorescence guided surgery will continue to redefine modern surgical oncology and neurosurgery.

SCOPE OF STUDY:

The report analyzes the Fluorescence Guided Surgery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (SPY Systems, PDE Systems, VS3 Iridium Systems, Other Types); Surgery (Open Surgery, Laparoscopy / Endoscopy Surgery); Application (Cancer Surgery Application, Cardiovascular Surgery Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • Accuray Incorporated
  • Arthrex, Inc.
  • Bracco Imaging S.p.A.
  • Curadel LLC
  • Elekta AB
  • Fluoptics
  • Getinge AB
  • Hamamatsu Photonics K.K.
  • Intuitive Surgical, Inc.
  • Karl Kaps GmbH & Co. KG
  • Karl Storz SE & Co. KG
  • Leica Microsystems (Danaher Corporation)
  • LI-COR Biosciences
  • Lumicell Inc.
  • Medtronic plc
  • Mizuho Medical Co., Ltd.
  • MolecuLight Inc.
  • NICO Corporation
  • Novadaq Technologies Inc. (Stryker)
  • Olympus Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fluorescence Guided Surgery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Preference for Precision-Guided Oncologic Surgeries Propels Market Growth
    • Advancements in Near-Infrared and Multispectral Imaging Improve Visualization Accuracy
    • Increasing FDA and CE Approvals for Targeted Imaging Agents Expand Clinical Use
    • Growing Application in Neurosurgery, Urology, and Reconstructive Surgery Broadens Scope
    • Integration With Robotic Surgery Platforms Enhances Surgical Workflow Synergies
    • Development of Target-Specific Fluorescent Dyes Improves Tumor Margin Identification
    • Growth in Minimally Invasive Surgery Drives Demand for Real-Time Visualization Tools
    • AI-Based Image Enhancement Technologies Enable Faster, More Accurate Interpretation
    • Hospital Investments in Hybrid Operating Rooms Support System Installations
    • Surgeon Training and Awareness Campaigns Boost Institutional Adoption Rates
    • Demand for Organ-Sparing Surgical Techniques Encourages Use in High-Precision Interventions
    • Strategic Collaborations Between Imaging System Manufacturers and Pharma Firms Accelerate Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fluorescence Guided Surgery Systems Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for SPY Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for SPY Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for SPY Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for PDE Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for PDE Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for PDE Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for VS3 Iridium Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for VS3 Iridium Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for VS3 Iridium Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Open Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Open Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Laparoscopy / Endoscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Laparoscopy / Endoscopy Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Laparoscopy / Endoscopy Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cancer Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Cancer Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Surgery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Cardiovascular Surgery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 164: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Fluorescence Guided Surgery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Fluorescence Guided Surgery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Fluorescence Guided Surgery Systems by Type - SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Type - Percentage Breakdown of Value Sales for SPY Systems, PDE Systems, VS3 Iridium Systems and Other Types for the Years 2015, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fluorescence Guided Surgery Systems by Surgery - Open Surgery and Laparoscopy / Endoscopy Surgery Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Surgery - Percentage Breakdown of Value Sales for Open Surgery and Laparoscopy / Endoscopy Surgery for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fluorescence Guided Surgery Systems by Application - Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fluorescence Guided Surgery Systems by Application - Percentage Breakdown of Value Sales for Cancer Surgery Application, Cardiovascular Surgery Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제